tiprankstipranks
Advertisement
Advertisement

PRTA Stock Latest News

Prothena Shareholders Reaffirm Board, Auditor and Pay Policies
Company AnnouncementsProthena Shareholders Reaffirm Board, Auditor and Pay Policies
8d ago
8K
PRTA
Biogen CELIA topline readout in Alzheimer’s ‘historic,’ says H.C. Wainwright
PremiumThe Fly
Biogen CELIA topline readout in Alzheimer’s ‘historic,’ says H.C. Wainwright
9d ago
DYN
ALEC
Analyst Reiterates Buy on Prothena, Maintaining $30 Price Target on CYTOPE and PRX012-TfR Platform Strength
PremiumRatings
Analyst Reiterates Buy on Prothena, Maintaining $30 Price Target on CYTOPE and PRX012-TfR Platform Strength
15d ago
PRTA
Prothena price target raised to $20 from $19 at Citizens
PremiumThe Fly
Prothena price target raised to $20 from $19 at Citizens
16d ago
PRTA
Prothena reports Q1 EPS 60c vs ($1.12) last year
PremiumThe Fly
Prothena reports Q1 EPS 60c vs ($1.12) last year
16d ago
PRTA
Prothena cuts FY26 net cash used view to $18M-$23M from $50M-$55M
PremiumThe FlyProthena cuts FY26 net cash used view to $18M-$23M from $50M-$55M
16d ago
PRTA
Prothena Corporation (PRTA) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Prothena Corporation (PRTA) Q1 Earnings Cheat Sheet
19d ago
PRTA
Prothena announces Novo Nordisk obtained FDA fast track for PRX004
Premium
The Fly
Prothena announces Novo Nordisk obtained FDA fast track for PRX004
26d ago
NVO
PRTA
Prothena names Annie Kingston as Chief Strategy Officer
PremiumThe Fly
Prothena names Annie Kingston as Chief Strategy Officer
1M ago
PRTA
Prothena (PRTA): Partner-Funded, Milestone-Rich Pipeline De-Risks Lead Programs and Supports Buy Rating
PremiumRatings
Prothena (PRTA): Partner-Funded, Milestone-Rich Pipeline De-Risks Lead Programs and Supports Buy Rating
2M ago
PRTA
Prothena achieves $50M clinical milestone payment from Novo Nordisk
PremiumThe Fly
Prothena achieves $50M clinical milestone payment from Novo Nordisk
3M ago
NVO
PRTA
Prothena Announces $100 Million Share Repurchase Program
PremiumCompany Announcements
Prothena Announces $100 Million Share Repurchase Program
3M ago
8K
PRTA
Prothena announces $100M share repurchase plan
PremiumThe FlyProthena announces $100M share repurchase plan
3M ago
PRTA
Prothena expects to end year with $255M in cash, equivalents
Premium
The Fly
Prothena expects to end year with $255M in cash, equivalents
3M ago
BMY
NVO
Prothena Earnings Call: Pipeline Progress, Risks Ahead
Premium
Company Announcements
Prothena Earnings Call: Pipeline Progress, Risks Ahead
3M ago
PRTA
Prothena: Transformative CYTOPE and TfR Platforms Underpin Long‑Term Upside and Support Buy Rating
PremiumRatings
Prothena: Transformative CYTOPE and TfR Platforms Underpin Long‑Term Upside and Support Buy Rating
3M ago
PRTA
Prothena reports Q4 EPS (40c), consensus (46c)
PremiumThe Fly
Prothena reports Q4 EPS (40c), consensus (46c)
3M ago
PRTA
PRTA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PRTA Earnings this Week: How Will it Perform?
3M ago
PRTA
Prothena Board Member Paula Cobb Resigns
PremiumCompany Announcements
Prothena Board Member Paula Cobb Resigns
5M ago
8K
PRTA
Prothena price target raised to $19 from $11 at Citizens JMP
PremiumThe FlyProthena price target raised to $19 from $11 at Citizens JMP
6M ago
PRTA
Prothena price target raised to $8 from $4 at BofA
Premium
The Fly
Prothena price target raised to $8 from $4 at BofA
6M ago
NVO
CHRO
Sell Rating for Prothena Due to Reliance on Partnered Programs and Uncertainties in Phase 3 Trials
Premium
Ratings
Sell Rating for Prothena Due to Reliance on Partnered Programs and Uncertainties in Phase 3 Trials
6M ago
PRTA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >